The novel approach of the medication represents a exciting development in the management of diabetes mellitus type 2. Different to existing drugs, tirzepatide targets two pathways – the GLP-1 hormone and the GIP https://tirzepatidepeptide363538.blogoxo.com/42409065/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment